PT141 10MG

Description

PT141-10MG

PT-141, also known as bremelanotide, is a synthetic cyclic peptide
classified as a melanocortin receptor agonist
(PubChem compound profile).
Supplied as 10mg of lyophilized powder per vial, this product is
intended exclusively for non-clinical laboratory and analytical research.

Product Highlights

• 10mg per vial in lyophilized powder format
• Cyclic seven-amino-acid peptide, also known as bremelanotide
  (PubChem)
• Synthetic analogue of alpha-melanocyte-stimulating hormone
  (alpha-MSH), with reported activity at melanocortin receptors
  including MC3R and MC4R
  (PT-141 receptor research)
• For qualified laboratory and analytical research use only

Research Focus

Published PT-141 research examines melanocortin receptor activation
and associated central nervous system signaling, including MC3R
and MC4R activity. Preclinical studies have also investigated
hypothalamic neuronal activation and behavioral responses related
to sexual function
(published PT-141 research).

These research findings describe the compound’s pharmacology,
not demonstrated benefits or approved uses of this laboratory
product. No suitability for human or veterinary administration
is stated or implied.

Specifications

• Compound: PT-141 (bremelanotide)
  (PubChem)
• Quantity: 10mg per vial
• Form: Lyophilized powder
• Structural class: Synthetic cyclic heptapeptide
  (PubChem)
• Pharmacological class: Melanocortin receptor agonist
  (PT-141 receptor research)
• Intended use: Non-clinical laboratory and analytical research

Important Notice

For research use only. Not for human consumption. Not for medical,
veterinary, diagnostic, or therapeutic use. This product must be
handled only by qualified professionals in an appropriate research
setting. Published research about PT-141 does not establish the
identity, purity, safety, or suitability of any individual product
batch; refer to the corresponding Certificate of Analysis for
available batch-specific testing.